Docetaxel

Država: Nova Zelandija

Jezik: angleščina

Source: Medsafe (Medicines Safety Authority)

Aktivna sestavina:

Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg

Dostopno od:

REX Medical Ltd

INN (mednarodno ime):

Docetaxel trihydrate 100.71 mg (equivalent to anhydrous docetaxel 80 mg)

Odmerek:

80 mg/mL

Farmacevtska oblika:

Concentrate for infusion

Sestava:

Active: Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

Enote v paketu:

Vial, glass, Diluent, 6 mL

Razred:

Prescription

Tip zastaranja:

Prescription

Izdeluje:

Cipla Ltd

Terapevtske indikacije:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

Povzetek izdelek:

Package - Contents - Shelf Life: Vial, glass, Diluent - 6 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 80 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Datum dovoljenje:

2006-06-23